Distribution of R factors among Shigella strains isolated in Japan.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D005664:Furazolidone / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D007564:Japan; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D010303:Paromomycin / Q000494:pharmacology; D010403:Penicillin Resistance; D012703:Serotyping; D012760:Shigella / Q000187:drug effects* / Q000302:isolation & purification; D013307:Streptomycin / Q000494:pharmacology; D013424:Sulfanilamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D013424:Sulfanilamides; D009268:Nalidixic Acid; D007612:Kanamycin; D005664:Furazolidone; D010303:Paromomycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin; D003091:Colistin